- Seaport, Hemab price IPOs, while Avalyn soars in Nasdaq debutA trio of biotechs priced their IPOs on Thursday into Friday morning, setting the stage for their public trading debuts with more than $850 million combined. Seaport Therapeutics, Hemab Therapeut…Endpoints · 2mo ago↗ source
- J&J axes pair of CAR-T therapies for lymphoma, citing evolving marketJohnson & Johnson is scrapping two CAR-T cell programs for B cell lymphoma amid a wave of approvals in recent years for cell therapies and antibody-based drugs addressing the disease. The dru…Endpoints · 2mo ago↗ source
- Boehringer appoints pharma veteran for corporate affairs post; BlueRock CSO heads for the exit→ Boehringer Ingelheim has brought in Christie Bloomquist as SVP, corporate affairs, US human pharma, and she’ll be president of the Boehringer Cares Foundation. Peer Review informed you about her…